Anaptysbio (ANAB) Operating Income (2016 - 2026)
Anaptysbio's Operating Income came in at -$34.64 million for Q1 2026, compared with -$27.54 million a year earlier.
Powered by 
Analysis
Anaptysbio (ANAB) Operating Income (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Anaptysbio reported Operating Income of $40.8 million; for FY2025, it was $47.9 million.
- Going back by year, Operating Income was -$114.95 million in FY2024, -$164.41 million in FY2023, -$115.15 million in FY2022 and -$56.81 million in FY2021.
- The Q1 2026 figure represents the lowest quarterly Operating Income since Q2 2024.
- Business Quant data shows ANAB's Operating Income at $66.9 million (Q4 2025), $34.7 million (Q3 2025) and -$26.17 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Anaptysbio | 1.41 Bn | 299.02 Mn | - | -34.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -34.64 Mn |
| Dec 31, 2025 | 66.90 Mn |
| Sep 30, 2025 | 34.70 Mn |
| Jun 30, 2025 | -26.17 Mn |
| Mar 31, 2025 | -27.54 Mn |
| Dec 31, 2024 | -9.67 Mn |
| Sep 30, 2024 | -22.76 Mn |
| Jun 30, 2024 | -40.32 Mn |
| Mar 31, 2024 | -42.20 Mn |
| Dec 31, 2023 | -42.14 Mn |
| Sep 30, 2023 | -37.73 Mn |
| Jun 30, 2023 | -40.14 Mn |
| Mar 31, 2023 | -44.40 Mn |
| Dec 31, 2022 | -25.97 Mn |
| Sep 30, 2022 | -29.63 Mn |
| Jun 30, 2022 | -27.80 Mn |
| Mar 31, 2022 | -31.75 Mn |
| Dec 31, 2021 | -31.16 Mn |
| Sep 30, 2021 | -6.76 Mn |
| Jun 30, 2021 | -533,000.00 |
API Access
Anaptysbio Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();